Skip to content

Immediate Implant Provisionalization

Soft Tissue Stability of Immediate Implant Placement With and Without Immediate Provisionalization: A Randomized Controlled Clinical Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07732647
Enrollment
44
Registered
2026-07-29
Start date
2026-08-01
Completion date
2028-08-31
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gum Disease

Brief summary

This research is studying gum tissue stability of dental implants placed at same appointment as the tooth extraction, with or without a provisional (temporary) crown.

Detailed description

This study aims to find out whether a new type of hybrid dental implant-which has a smooth surface near the gums to make cleaning easier and potentially lower the risk of infection-can help improve gum health and reduce implant complications. It also compares two common treatment approaches after tooth removal: placing a temporary provisional crown immediately versus using a standard healing cap. By studying these options, we hope to learn which method provides better healing, protects the gums more effectively, and leads to fewer problems around the implant.

Interventions

DEVICEDental implant placement

A dental implant will be placed after tooth extraction.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Physical status according to the American Society of Anesthesiology (ASA) I or II, which include patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases. * Periodontally healthy or with treated periodontitis with good oral hygiene ((FMPS) and (FMBS) ≤15%, measured at four sites per tooth). * Presence of one non-restorable maxillary anterior tooth (from #5 to #12 sites) * More than 20 occluding teeth with stable occlusion. * Nonsmokers or smokers \< 10 cig/day (self-reported).

Exclusion criteria

* Presence of uncontrolled or untreated periodontal disease. * Presence of active periapical infection. * Subjects taking medications known to modify bone metabolism or those that can interfere with the normal wound healing (such as bisphosphonates, corticosteroids, hormone replacement therapy, parathyroid hormone, denosumab, strontium ranelate, etc.), or those with uncontrolled systemic diseases or conditions that may similarly affect the patient's healing (osteoporosis, osteopenia, hyperparathyroidism, Paget's disease, uncontrolled diabetes (HBA1c \> 8)). * Pregnant subjects or individuals attempting to get pregnant (self-reported) * Subjects smoking 10 or more cigarettes a day, or those with a history of drug or alcohol abuse (self-reported) * Subjects unable to maintain adequate oral hygiene * Insufficient restorative space or bite collapse. * Lack of primary implant stability assessed intrasurgically.

Design outcomes

Primary

MeasureTime frameDescription
Linear changes of gum tissue architecture1 month and 4 months after baseline surgery, 6 months and 12 months after crown deliveryDigitally measured soft tissue changes in mm\^2 using intraoral and CBCT scans
Volumetric changes of gum tissue architecture1 month and 4 months after baseline surgery, 6 months and 12 months after crown deliveryDigitally measured soft tissue changes in mm\^3 using intraoral and CBCT scans

Secondary

MeasureTime frameDescription
Changes in marginal bone5 months after baseline surgery, 6 months and 12 months after crown deliveryDigitally measured marginal bone changes from radiographs in mm
Patient-reported satisfaction14 days after baseline surgeryPercentage of pain reported via post-operative diary
Microbial profileBaseline, 4 months after baseline surgery, 6 months and 12 months after crown deliveryAmount of microbes and immune cells measured as means and medians with standard deviations.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORHom-Lay Wang, DDS MSD PhD

Department of Periodontics and Oral Medicine, University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026